{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:20:41Z","timestamp":1795123241628,"version":"4.10.3"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"name":"Hologic","id":[{"id":"https:\/\/ror.org\/02td4ph55","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To compare treatment failure and factors associated with failure between laparoscopic radiofrequency ablation (RFA) of leiomyomata and laparoscopic myomectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We analyzed data from the multicenter prospective ULTRA (Uterine Leiomyoma Treatment with Radiofrequency Ablation) study, which investigated laparoscopic RFA and laparoscopic myomectomy for symptomatic uterine leiomyomata. Our primary outcome was receipt of any subsequent procedure (surgical failure) for leiomyomata within 2 years of the procedure. Our secondary outcome was composite failure (surgical failure or any self-reported failure, eg, continued leiomyomata symptoms affecting quality of life) within 2 years of the procedure. Odds ratios (ORs) were generated from multivariable logit models adjusting for a priori selected covariates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>We identified significant baseline differences between our groups. The RFA group (n=231) was older and had higher body mass index (BMI), gravidity, and parity than the myomectomy group (n=110). In the RFA group, 15.2% experienced surgical failure compared with 3.8% in the myomectomy group (adjusted odds ratio [aOR] 4.17; 95% CI, 1.39\u201312.50), and 46.4% experienced composite failure in the RFA group compared with 25.5% in the myomectomy group (aOR 3.18; 95% CI, 1.80\u20135.60). Submucosal leiomyomata were associated with failure in the RFA group (OR 2.76; 95% CI, 1.21\u20136.28); there was a nonsignificant trend toward failure in the myomectomy group (OR 3.00; 95% CI, 0.99\u20139.05). Lateral leiomyomata were associated with higher odds of RFA failure (OR 2.49; 95% CI, 1.32\u20134.69), but no leiomyoma position was associated with myomectomy failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Laparoscopic RFA of leiomyomata is associated with higher odds of surgical and composite failure compared with laparoscopic myomectomy at 2 years, even after adjusting for baseline differences between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, NCT02100904.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006444","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:00:33Z","timestamp":1791925233000},"page":"723-733","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Treatment Failure After Laparoscopic Radiofrequency Ablation Compared With Myomectomy"],"prefix":"10.1097","volume":"148","author":[{"given":"Katherine S.","family":"Brito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schembri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Parvataneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Varon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naghmeh","family":"Salamat-Saberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Sobolewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyini","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa L.","family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Elaine","family":"Waetjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"R1-20261119","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in Black and White women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20261119","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG"},{"key":"R3-20261119","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bpobgyn.2008.01.008","article-title":"Clinical presentation of fibroids","volume":"22","author":"Gupta","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R4-20261119","doi-asserted-by":"crossref","first-page":"211 e1","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20261119","first-page":"225","article-title":"The impact of uterine leiomyomas on reproductive outcomes","volume":"62","author":"Cook","year":"2010","journal-title":"Minerva Ginecol"},{"key":"R6-20261119","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bpobgyn.2017.10.001","article-title":"Alternatives to hysterectomy: the burden of fibroids and the quality of life","volume":"46","author":"Fortin","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R7-20261119","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s13669-016-0183-x","article-title":"Radiofrequency ablation of uterine fibroids: a review","volume":"5","author":"Lee","year":"2016","journal-title":"Curr Obstet Gynecol Rep"},{"key":"R8-20261119","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1089\/lap.2019.0550","article-title":"Clinical performance of radiofrequency ablation for treatment of uterine fibroids: systematic review and meta-analysis of prospective studies","volume":"29","author":"Bradley","year":"2019","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"R9-20261119","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/AOG.0b013e31828b7962","article-title":"Outpatient procedure for the treatment and relief of symptomatic uterine myomas","volume":"121","author":"Chudnoff","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R10-20261119","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijgo.2013.11.012","article-title":"Laparoscopic radiofrequency volumetric thermal ablation of fibroids versus laparoscopic myomectomy","volume":"125","author":"Brucker","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"R11-20261119","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1016\/j.jmig.2014.08.598","article-title":"The ULTRA registry: uterine leiomyoma treatment with radiofrequency ablation","volume":"21","author":"Jacoby","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"key":"R12-20261119","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejogrb.2013.08.036","article-title":"Measurement of uterine fibroid volume: a comparative accuracy and validation of methods study","volume":"171","author":"Quinn","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R14-20261119","doi-asserted-by":"crossref","first-page":"e2312701","DOI":"10.1001\/jamanetworkopen.2023.12701","article-title":"Presence of fibroids on transvaginal ultrasonography in a community-based, diverse cohort of 996 reproductive-age female participants","volume":"6","author":"Huang","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R15-20261119","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/jwh.2020.9001","article-title":"Uterine fibroids in Black women: a race-stratified subgroup analysis of treatment outcomes after laparoscopic radiofrequency ablation","volume":"31","author":"Berman","year":"2022","journal-title":"J Womens Health (Larchmt)"},{"key":"R16-20261119","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"key":"R17-20261119","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/AOG.0000000000005557","article-title":"Long-term risk of reintervention after surgical leiomyoma treatment in an integrated health care system","volume":"143","author":"Mitro","year":"2024","journal-title":"Obstet Gynecol"},{"key":"R18-20261119","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.fertnstert.2017.11.033","article-title":"Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis","volume":"109","author":"Sandberg","year":"2018","journal-title":"Fertil Steril"},{"key":"R19-20261119","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1089\/jwh.2017.6752","article-title":"Reintervention rates after myomectomy, endometrial ablation, and uterine artery embolization for patients with uterine fibroids","volume":"27","author":"Davis","year":"2018","journal-title":"J Womens Health (Larchmt)"},{"key":"R20-20261119","first-page":"9S","article-title":"Radiofrequency ablation of uterine leiomyomata: a new minimally invasive hysterectomy alternative [abstract]","volume":"99","author":"Lee","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R21-20261119","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jmig.2005.07.121","article-title":"122: three year follow-up post radiofrequency ablation of uterine leiomyomata [abstract]","volume":"12","author":"Lee","year":"2005","journal-title":"J Minim Invasive Gynecol"},{"key":"R22-20261119","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jmig.2011.02.006","article-title":"Laparoscopic ultrasound-guided radiofrequency volumetric thermal ablation of symptomatic uterine leiomyomas: feasibility study using the Halt 2000 Ablation System","volume":"18","author":"Garza Leal","year":"2011","journal-title":"J Minim Invasive Gynecol"},{"key":"R23-20261119","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1477-7525-11-139","article-title":"Radiofrequency volumetric thermal ablation of fibroids: a prospective, clinical analysis of two years' outcome from the Halt trial","volume":"11","author":"Guido","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"R24-20261119","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jmig.2014.02.015","article-title":"Three-year outcome of the Halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas","volume":"21","author":"Berman","year":"2014","journal-title":"J Minim Invasive Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:00:56Z","timestamp":1795122056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006444","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"2026-04-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}